Board of Directors

Philip Arlen, PhD | Pandora Genomics

Dr. Philip Arlen is the Chief Scientific Officer of Pandora Genomics. Dr. Arlen earned a BS in Biology from Cornell University and PhD in microbiology, immunology and molecular genetics from the University of California. His dissertation work was based on genomic variations that impact responses to antiviral therapy. His post-doctoral work focused on genetic engineering for vaccine design and biopharmaceutical delivery. Dr. Arlen has spent the past 15 years investigating innovative technologies and cultivating close relationships with clinicians in order to improve human health.

Back to top

Irma Becerra-Fernandez, PhD | Florida International University


Back to top

Patti Breedlove

Patti Breedlove | Sid Martin Biotechnology Incubator

Patti Breedlove, MS, Associate Director of the UF’s Sid Martin Biotechnology Incubator, led development of the Florida BioDatabase and serves on the boards of BioFlorida, the Florida Research Park Network, Alachua/Bradford County Workforce and Progress Park Owner’s Association. She has committee roles at the Florida Chamber Foundation, Enterprise Stakeholder’s Council and SEBIO.

Back to top


Jon Cantor

Jonathan D. Cantor, Reynolds | Smith & Hills

Mr. Cantor is an Architect, trained in the programming, design and construction of Science and Technology applications, working both nationally and internationally with a wide range of public and private clients. Mr. Cantor has also been a longtime advocate for the strengthening of the Life Sciences sectors through his active participation on multiple committees and task force throughout his region.

Back to top



Shailesh Chavan, MD | Biotest Pharmaceuticals

Dr. Chavan brings more than a decade of leadership and management experience within the bio-pharmaceutical industry. After playing leadership roles at ClinTec International, Tengion, Cephalon and University of Florida, in 2008, he joined Biotest Pharmaceuticals where he leads clinical development, drug safety, medical affairs and regulatory affairs. Dr. Chavan’s expertise spans drug and device development in multiple therapeutic areas including immunology, oncology, transplantation, neurology, cardiology and regenerative medicine. Apart from clinical trial management he has been active in biotech business development, due diligence process, commercial strategies, strategic alliances and partnerships. Dr. Chavan received his M.B.B.S degree from Seth G.S. Medical College, India followed by residency in Internal Medicine at the Bombay Hospital Institute of Medical Sciences, India. 

Back to top



Les Croland

Leslie J. Croland | Duane Morris

Leslie (Les) practices in the areas of private equity financings, emerging companies, M&A’s, securities and general corporate law. Les counsels domestic and foreign corporations, and also advises startup companies and entrepreneurs, VC companies, underwriters, and sellers and purchasers of businesses. Les is Co-Chair of the firm's Life Sciences Practice Group.

Back to top


David Day

David L. Day | University of Florida (UF)

David Day joined the Office of Technology Licensing at UF as Director in 2001 where he oversees the commercialization efforts of all UF technologies. He also serves as Director of the Sid Martin Biotechnology Incubator, and serves on many boards including the McKnight Brain Institute Advisory Panel, the Executive Committee of the Florida Research Consortium, and the Executive Committee of the Southeastern Bio Investors Forum.

Back to top



Susan Forbes | OneBlood


Back to top

Santiago Galvez

Santiago Galvez | Beckman Coulter


Back to top



Steven Gold | Xhale, Inc.

Mr. Gold’s experience includes private company formation, funding and successful exit strategies. He is a graduate of Yale University (BA), the University of Florida Levin School of Law and College of Medicine (JD, MPH), and the University of Pennsylvania School of Medicine Center for Bioethics (MBE). Steve has served in the chambers of Justice Charles Wells of the Florida Supreme Court and has also worked for then Attorney General, Charlie Crist, as a Deputy Solicitor General. He is a part-time Adjunct Professor for undergraduate and graduate level courses in medicine, law and medical ethics.

Back to top


John Igoe | Edwards Wildman Palmer LLP

John is an experienced corporate lawyer with knowledge of many areas of business law. He learns the operations and businesses of his clients in depth in order to be in a position to render legal advice in the context of their goals. John began his legal career in the Firm's Providence office in 1981 and moved to the West Palm Beach office in 1983 to assist in building the Firm's practice in Florida. John has extensive experience working with start-up companies and entrepreneurs as they form and grow their businesses. This focus area is supported by the Firm's Helping Innovators Thrive (HIT) program ( which provides support and affordable access to strategic legal advice for qualifying entrepreneurs and young companies. John also represents venture capital funds. John has worked in the venture capital arena since he started practicing law in 1981.  He has advised start-up companies from inception to IPO and beyond. He has a strong reputation in Florida for his knowledge of venture capital transactions and securities law. He also works on complex corporate structuring, mergers and acquisitions, joint ventures, and general corporate matters. John was recognized as a Top Lawyer in the South Florida Legal Guide 2010, 2011 and 2013 in the area of private equity.

Back to top


Dawn Johnson, PhD | Scripps Florida

 Dawn Johnson is the Senior Director of Florida Operations for the Scripps Florida campus. She earned her PhD in Neuroscience from the University of Wisonsin-Madison and did her postdoctoral training at the University of Miami. Before joining The Scripps Research Institute in May, Dr. Johnson was the Associate Director for Science Management at the National Institute of Mental Health’s Intramural Research Program on the NIH campus in Bethesda MD.

Back to top

Norma Sue Kenyon | University of Miami


Back to top

William Knab

William Knab | Matrix Technology Management

Over 25 years of medical device marketing, product development and business leadership experience. Drove successful new ventures at Baxter International, Haemonetics, Medisystems and two successful start-ups, HemoCleanse and Renal Solutions. Founded Matrix Technology Management in 2004, a consulting organization focused on business and product development in the Medical Device industry. Started BioFlorida’s Southwest Chapter in 2008. Education background: BS, Biology from Western Michigan University, post graduate work in Bioengineering at the University of Utah, MBA from the Kellogg School of Management at Northwestern University. Project Management Professional certification from the Project Management Institute.

Back to top

Glenn Ladwig | Saliwanchik, Lloyd & Eisenschenk

Glenn P. Ladwig, a native Floridian, moved to Gainesville to further his education, where he remained to raise a family and pursue his legal career. In addition to his law degree from Stetson University College of Law, Glenn has a Bachelor’s of Science degree in Biology from Saint Leo University, and has two Master’s degrees from the University of Florida, in Medical Sciences and Pharmacy and Pharmaceutical Sciences. Glenn is a registered patent attorney, is Board Certified in Intellectual Property by the Florida Bar, and is a Certified Licensing Professional. His clients include individuals, companies, universities and research institutions. Since starting his legal career nearly fifteen years ago, Glenn has helped organize breakout sessions at BioFlorida’s Annual Conference, and has been a speaker and moderator on numerous occasions.

Back to top

John Lima | Nemours Children's Clinic

Dr. Lima is the Director of the Center for Pharmacogenomics and Translational Research at the Nemours Children’s Clinic in Jacksonville, FL; and Principal Investigator of the American Lung Association Asthma Clinical Research Centers (ACRC), Nemours Children’s Clinic/University of FL Consortium. Dr. Lima received his PharmD degree from the University of Michigan and completed fellowship training in Clinical Pharmacokinetics at the SUNY at Buffalo. Dr. Lima has held faculty positions at the Ohio State University and at the University of Tennessee in Memphis where he was Professor of Clinical Pharmacy and Pharmaceutical Sciences. In 1998, Dr. Lima accepted his current position. Dr. Lima chairs the Genetics Working Group of the ALA ACRC, is a member of several professional organizations and is a member of the editorial board for several journals. He is on the Board of Directors for the American Lung Association of Florida. Dr. Lima’s research is currently focused in pharmacogenomics and personalized medicine.

Back to top


Valerie McDevitt | University of South Florida (USF) Research Foundation

Valerie Landrio McDevitt is a U.S. registered patent attorney and Assistant Vice President at the University of South Florida Division of Patents and Licensing, which acts as the main university contact for industry partners and start-up companies interested in technology transfer. During her more than ten year tenure at USF there has been significant improvement and advancement in licensing, revenue, and commercialization of early stage technology. Valerie was appointed by then Governor Crist and served on the Task Force for the study of Biotech Competitiveness and currently sits on the USPTO’s Patents Public Advisory Committee. She is a certified licensing professional through LES, a member of the Georgia and Florida bars, and is admitted to practice before the Federal Patent and Trademark Office.

Back to top

Leslie Molony

Leslie Molony, PhD | Sanford-Burnham Medical Research Institute at Lake Nona

Leslie Molony, PhD is Senior Director, Office of Technology Management and Commercialization at Sanford-Burnham, and leads the Institute’s activities to develop and implement strategies for new collaborations, licensing technology and spinning off companies. She received her BS in Physics and a PhD in Cell Biology both from Duke University.

Back to top


Karen Moore

Karen B. Moore | Moore Consulting Group

Karen Moore is an acknowledged leader in the media relations, public relations, crisis communications and public affairs arena. Called by Henry Kissinger, “one tough lady,” Karen is the CEO and Founder of Moore Consulting Group. This innovative marketing communications firm, with offices in Tallahassee/Jacksonville/Miami/Washington, D.C., is one of the largest independently-owned PR firms in Florida, representing clients across the U.S. and the Caribbean.

Back to top


James Mule

James J. Mulé, PhD | Moffitt Cancer Center & Research Institute

Dr. Mulé is Executive Vice President, the Michael McGillicuddy Endowed Chair for Melanoma Research and Treatment, and the Director of Cell-Based Therapies at the Moffitt Cancer Center. Dr. Mulé received his formal training at the Fred Hutchinson Cancer Center and the University of Washington Medical Center in Seattle, Washington and at the Surgery Branch, Division of Cancer Treatment, National Cancer Institute, NIH, Bethesda, Maryland.

Back to top


Ramaswamy Narayanan, PhD

Ramaswamy Narayanan, PhD | Florida Atlantic University (FAU)

Ramaswamy Narayanan serves as Assistant Vice President for Research in the Division of Research and Associate Dean of Research in the College of Science at FAU. He received his PhD in biochemistry from the National University of Dublin in Ireland and did his postdoctoral work at the NCI, NIH and at the U.S. Centers for Disease Control. His work at FAU has led to two issued patents and provided the basis for the first biotech startup at the University.

Back to top


Greg Nelson

Gregory A. Nelson | Novak Druce Connelly Bove + Quigg LLP

Gregory Nelson represents clients in all phases of patent, trademark and copyright law, including prosecution, licensing and litigation. Mr. Nelson serves as the Secretary and General Counsel of BioFlorida. He is a past chair and board member of the Enterprise Development Corporation, is a founding member and co-chair of the Florida Chapter of the Licensing Executives Society and a frequent lecturer, panelist and moderator on intellectual property topics.

Back to top


Michael Paredes | Genentech

R. Michael Paredes is a health care government affairs professional with 18 years experience in both the public and private sectors. As Senior Government Affairs Manager for Genentech, Inc., Mike is directly responsible for all advocacy efforts on behalf of Genentech before state executive agencies, legislatures, regulatory bodies and other governmental organizations in an eight state region in the southeast United States. He also worked for and managed legislative efforts for Hoffman-LaRoche Pharmaceuticals, and the Walt Disney World Company. Mike was the Director of Legislative Affairs for the Florida Agency for Health Care Administration and the Florida Department of Health under Governor Jeb Bush. He began his legislative career working for the Florida House of Representatives and the Florida Senate. Mike graduated from Florida State University with a degree in Economics.

Back to top


Phil Piser

Phil Piser | Cherry, Bekaert & Holland, LLP

Phil is a Certified Public Accountant and an Audit Partner at CB&H with over 30 years of experience providing accounting and audit services to both publicly traded and closely held companies. Phil is the regional director for the Accounting and Auditing Practice for the Firm’s Florida offices. Phil either serves as, or has served as, the engagement partner on most of theTampa office life sciences clients. Phil has significant experience providing services to clients in the bioscience, manufacturing, leisure time, healthcare, distribution and insurance sectors. In addition, he coordinates many of the Firm’s business consulting services locally, including profit enhancement studies and business planning services. Phil is an active member of the Tampa chapter of the Association for Corporate Growth and Financial Executives Institute and has made presentations to both organizations in the area of capital formation and other relevant topics.

Back to top



Rocky Rodriguez | McDonald Hopkins

Raquel (Rocky) has more than 25 years of extensive experience counseling clients on a wide variety of government, business and litigation matters. From 2002 through 2006, she was General Counsel to former Florida Governor Jeb Bush. In that capacity, Rocky worked on some of the most complex and urgent issues facing the state. This included conceiving and co-drafting the legislation for and negotiating the largest economic development project in state history, a $310 million economic incentive grant to The Scripps Research Institute. In addition to her four years in the Florida Governor’s office, Rocky was executive director of the London-based MULTILAW, Multinational Association of Independent Law Firms. Her law firm experience includes 15 years at Greenberg Traurig LLC, where she was a shareholder for six years, and four years as a partner at McDermott Will & Emery LLP. 

Back to top

James Rosen | Intersouth

Jimmy joined the life science team at Intersouth in 2005. Previously, he spent 15 years in clinical, research and financial positions in the healthcare and biotechnology sectors. For three years, he was an equity research analyst at Brean Murray & Co. covering biopharmaceuticals, genomics, generics, drug delivery and medical device companies. He has also worked in clinical research roles at Duke University Medical Center’s Comprehensive Cancer Center and completed projects for the NCI.

Back to top


Mel Rothberg

Mel Rothberg | Vaccine & Gene Therapy Institute Florida

Mel Rothberg is the Chief Operating Officer of VGTI Florida. Mr. Rothberg brings more than 40 years of experience to VGTI as a national and international business executive from companies such as, Viragen, Inc., Althin Medical Inc., CD Medical Inc. (Dow Chemical), Cordis Dow Corporation and Goodyear. He has extensive international experience in all major markets with a particular emphasis in Europe and the Far East.

Back to top


Thaddeus Seymour

Thaddeus Seymour, Jr., PhD | Lake Nona

Thad Seymour is the Vice President & General Manager, Health & Life Sciences at Lake Nona. Thad leads strategic planning and business development for Lake Nona’s new “medical city.” His role includes the supervision of all health and life sciences planning, new business ventures and institutional recruitment. Thad holds a BA from Dartmouth College, an MA and PhD from the University of Wisconsin, and an MBA from the Kellogg Graduate School of Management at Northwestern University.

Back to top


Svetlana Shtrom

Svetlana Shtrom, PhD | University of Central Florida (UCF)

Dr. Shtrom is currently directing the commercial development of technologies at UCF’s Office of Research & Commercialization. Svetlana has over 13 years of experience in business development and technology management. She holds an MBA from UCF. She was a postdoctoral fellow at the NIH, and received a PhD in cell biology from the University of California at San Francisco and a BS in molecular genetics from The Ohio State University.

Back to top




Holly Snow | Amgen


Back to top

Deborah Sutherland, PhD | University of South Florida Research Foundation

Dr. Sutherland is the CEO for the Center for Advanced Medical Learning and Simulation (CAMLS); Associate Vice President, USF Health; and Associate Dean, Continuing Professional Development, USF Health Morsani College of Medicine. Dr. Sutherland has strategic and administrative responsibility for the continuing professional development activities of the Morsani College of Medicine, as well as the Colleges of Nursing and Public Health. She is also the CEO for HPCC, the Health Professions Conferencing Corporation, and president of USF Health’s International Foundation in Panama. Dr. Sutherland serves in a leadership role with national and state organizations that accredit CME programs. On the national level, she is an accreditation surveyor for the Accreditation Council for Continuing Medical Education and served six years on the ACCME’s Accreditation Review Committee (ARC). On the state level, she works with the Florida Medical Association’s CME Committee to accredit intrastate providers of continuing medical education. Dr. Sutherland is also involved with the Society for Academic Continuing Medical Education and has served as southeastern regional representative, chaired the Society’s membership committee, and presently serves as Treasurer of the Society. 

Back to top

Jack Sullivan

Jack Sullivan | Florida Research Consortium (FRC)

Jack is the President of the FRC. The FRC believes economic development occurs when people develop “new recipes” for combining earths limited resources in higher value, sustainable ways. He joined FRC in 2002 after 20 years in the private sector as a business owner and volunteer.

Back to top



James Talton PhD

James D. Talton, PhD | Nanotherapeutics, President and CEO

Dr. Talton is co-founder, President and CEO at Nanotherapeutics, and co-inventor of Nanotherapeutics’ technologies. Dr. Talton received his BS and MS in Materials Science and Engineering and his PhD in Pharmaceutical Sciences from the University of Florida. Dr. Talton is also on the Advisory Council at Keck Graduate Institute and has been a reviewer for the NIH for over six years.

Back to top


Hal Valeche

Hal Valeche | York Street Capital Advisors, Representing Enterprise Florida

Mr. Valeche attended Yale University and graduated with a BA in American Studies. Upon graduation Mr. Valeche entered the U.S. Navy flight training program in Pensacola, Florida. After leaving the Navy, Mr. Valeche attended the Wharton School, where he received an MBA in Finance. Mr. Valeche was appointed to the Board of Directors of Enterprise Florida in 2009 and was named chairman of its Technology, Entrepreneurship and Capital Committee.

Back to top


William Warren

William L. Warren, PhD | Sanofi Pasteur VaxDesign Campus

William is a Vice President and heads the VaxDesign campus of Sanofi Pasteur. The VaxDesign campus specializes in biomimetic systems. Warren is a member of the Research and Development Management Committee, External Innovation Executive Committee, and the Senior Leadership Team at Sanofi Pasteur. He received his BSc Honors and PhD degrees in Engineering Science from The Pennsylvania State University.

Back to top


Stephanie Warrington

Stephanie Warrington | TrueMotion Spine

Ms. Warrington brings to her leadership role at TrueMotion Spine more than 18 years of health care industry experience as well as experience in corporate development, licensing, HR, intellectual property and commercialization of biomedical and engineering technologies. From 2005-2011 Ms. Warrington was Co-Founder and VP Corporate Development for Xhale, Inc. and its spin-off HyGreen, Inc. As President of Synogen Development Group, she has co-founded 7 medical technology start-ups since 2004 to commercialize a range of disruptive healthcare applications including orthopedic implants, diagnostic devices, pharmaceutical formulations, neurotechnology, patient monitoring devices, and healthcare IT services. Ms. Warrington is also the 2013-2015 Chairman of the BioFlorida Board of Directors, having served as both a Director and Committee Chair for several years. 

Back to top

Sue Washer

Sue Washer | Applied Genetic Technologies Corporation (AGTC)

Sue Washer is the President and CEO of AGTC. She has a degree in biochemistry from Michigan State University and an MBA from the University of Florida where she was one of the first graduates from the Business School’s Entrepreneurship program. Sue has 10 years of pharmaceutical management and research experience from Abbott Labs and Eli Lilly and 15 years of senior management experience with entrepreneurial firms in Florida including three start-ups.

Back to top


Claudia Zylberberg PhD

Claudia Zylberberg, PhD | Akron Biotech

Dr. Zylberberg serves as the Chief Executive Officer of Akron Biotech, a company that develops, manufactures and markets under cGMP, biotools, and high end cell culture products for the R&D and stem cell industries. With a PhD in biotechnology from the University of British Columbia and the University of Buenos Aires, Dr. Zylberberg has over 20 years of experience in the international biopharmaceutical industry.

Back to top



Powered by Affiniscape - Web Content and Association Membership Management